IgA deficiency
Selective IgA Deficiency is a primary immunodeficiency disorder characterized by an isolated deficiency of Immunoglobulin A (IgA), which is one of the most common types of antibody produced in the mucous membranes of the body. This condition leads to an increased susceptibility to infections, particularly of the respiratory and gastrointestinal tracts. Despite its potential to compromise the immune system, many individuals with Selective IgA Deficiency are asymptomatic and may not be aware of their condition.
Causes and Genetics[edit | edit source]
The exact cause of Selective IgA Deficiency is not fully understood, but it is believed to involve a combination of genetic and environmental factors. It has been observed to occur more frequently in individuals with certain genetic backgrounds, suggesting a hereditary component. However, no single gene has been identified as responsible for the condition.
Symptoms[edit | edit source]
Symptoms of Selective IgA Deficiency can vary widely among affected individuals. Some may remain completely asymptomatic, while others may experience recurrent infections, particularly sinus and lung infections, and gastrointestinal disorders. There is also an increased risk of developing autoimmune diseases, allergies, and asthma.
Diagnosis[edit | edit source]
Diagnosis of Selective IgA Deficiency is typically made through blood tests that measure levels of immunoglobulins. A significantly reduced level of IgA, with normal levels of other immunoglobulins (IgG and IgM), is indicative of the condition.
Treatment[edit | edit source]
There is no cure for Selective IgA Deficiency, and treatment is generally aimed at managing symptoms and preventing infections. This may include the use of antibiotics for bacterial infections and immunizations to prevent infections. Individuals with the condition should also be monitored for the development of autoimmune diseases and other complications.
Epidemiology[edit | edit source]
Selective IgA Deficiency is the most common primary immunodeficiency, affecting approximately 1 in 500 to 1 in 700 individuals in the general population. It occurs more frequently in individuals of European descent.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
